Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study. Chornenki NLJ, Siegal DM, Qamar K, Woolgar S, et al. Leuk Res 2022;113:106788.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chornenki NLJ, Siegal DM, Qamar K, Woolgar S, et al. Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study. Leuk Res 2022;113:106788.
PMID: 35042128